Various skin manifestations related to inflammatory bowel disease: A nationwide cross-sectional study on the Korean population
- PMID: 33608949
- DOI: 10.1111/1346-8138.15676
Various skin manifestations related to inflammatory bowel disease: A nationwide cross-sectional study on the Korean population
Abstract
Inflammatory bowel disease (IBD) presents with various extraintestinal manifestations. As part of them, various skin diseases are suggested to be related to IBD. We aimed to identify the epidemiology and risk of developing skin manifestations in patients with IBD. We used Korean insurance claims data and selected patients with IBD and age/sex-matched non-IBD subjects between 2013 and 2017 using the diagnosis code and prescription records of IBD-specific medications. The prevalence and risk of concurrent skin diseases were estimated. We identified 64 837 patients with IBD. Reactive skin eruptions including pyoderma gangrenosum and erythema nodosum were associated with IBD with highest odds ratios among three categories of reactive, inflammatory, and autoimmune skin diseases. Inflammatory skin diseases including rosacea, psoriasis, atopic dermatitis, hidradenitis suppurativa, and acne conglobata were significantly associated with IBD, but the association was less marked compared to reactive skin eruptions. The patients with IBD also had a higher risk of autoimmune skin diseases including vitiligo and alopecia areata than non-IBD subjects. We determined that IBD was related to various skin diseases including reactive, inflammatory, and autoimmune skin diseases. Considering these relationships can allow better management of patients with IBD and comorbid skin diseases.
Keywords: Crohn's disease; epidemiology; inflammatory bowel disease; skin disease; ulcerative colitis.
© 2021 Japanese Dermatological Association.
Similar articles
-
Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.J Gastroenterol Hepatol. 2014 Feb;29(2):291-5. doi: 10.1111/jgh.12352. J Gastroenterol Hepatol. 2014. PMID: 23927379
-
Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study: Classification: Epidemiology.Br J Dermatol. 2022 Nov;187(5):692-703. doi: 10.1111/bjd.21704. Epub 2022 Aug 3. Br J Dermatol. 2022. PMID: 35718888 Free PMC article.
-
Inflammatory bowel disease is associated with an increased risk of inflammatory skin diseases: A population-based cross-sectional study.J Am Acad Dermatol. 2017 Jan;76(1):40-48. doi: 10.1016/j.jaad.2016.08.022. Epub 2016 Oct 25. J Am Acad Dermatol. 2017. PMID: 27793451
-
[The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].Acta Med Croatica. 2013 Apr;67(2):195-201. Acta Med Croatica. 2013. PMID: 24471303 Review. Croatian.
-
[Cutaneous and mucosal manifestations of inflammatory bowel diseases].Orv Hetil. 2000 Jun 18;141(25):1391-5. Orv Hetil. 2000. PMID: 10934882 Review. Hungarian.
Cited by
-
Prevalence and Association of Autoimmune Comorbidities Among Adults with Vitiligo: A Systematic Literature Review and Meta-analysis of USA-Based Studies.Dermatol Ther (Heidelb). 2025 Aug 19. doi: 10.1007/s13555-025-01506-y. Online ahead of print. Dermatol Ther (Heidelb). 2025. PMID: 40828230 Review.
-
Beyond skin white spots: Vitiligo and associated comorbidities.Front Med (Lausanne). 2023 Feb 23;10:1072837. doi: 10.3389/fmed.2023.1072837. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36910477 Free PMC article. Review.
-
The Relationship Between Rosacea and Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.Dermatol Ther (Heidelb). 2023 Jul;13(7):1465-1475. doi: 10.1007/s13555-023-00964-6. Epub 2023 Jun 20. Dermatol Ther (Heidelb). 2023. PMID: 37338720 Free PMC article. Review.
-
The Skin and Gut Microbiome in Hidradenitis Suppurativa: Current Understanding and Future Considerations for Research and Treatment.Am J Clin Dermatol. 2022 Nov;23(6):841-852. doi: 10.1007/s40257-022-00724-w. Epub 2022 Sep 18. Am J Clin Dermatol. 2022. PMID: 36116091 Review.
-
Gut microbiota does not play a mediating role in the causal association between inflammatory bowel disease and several its associated extraintestinal manifestations: a Mendelian randomization study.Front Immunol. 2024 Jan 15;14:1296889. doi: 10.3389/fimmu.2023.1296889. eCollection 2023. Front Immunol. 2024. PMID: 38288127 Free PMC article.
References
REFERENCES
-
- Brown SJ, Mayer L. The immune response in inflammatory bowel disease. Am J Gastroenterol 2007; 102: 2058-2069.
-
- Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 2001; 96: 1116-1122.
-
- Huang BL, Chandra S, Shih DQ. Skin manifestations of inflammatory bowel disease. Front Physiol 2012; 3: 13.
-
- Veloso FT. Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome? World J Gastroenterol 2011; 17: 2702-2707.
-
- Marzano AV, Borghi A, Stadnicki A, Crosti C, Cugno M. Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy. Inflamm Bowel Dis 2014; 20: 213-227.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials